Trial Profile
Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in WA17822 [EXTENSION OF 700006623]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2014
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms GROWTH95
- Sponsors Roche
- 20 Mar 2014 New source identified and integrated (European Clinical Trials Database).
- 20 Mar 2014 New trial record